Prognosis following curative resection of the upper gastrointestinal tract;Prognosen efter kurativ resektion af øvre gastrointestinal cancer

Ugeskrift for Laeger

Volumn 170, Issue 49, 2008, Pages 4040-4044

  Fristrup, Claus Wilki ^a,b   Pless, Torsten ^a   Nielsen, Henning Overgaard ^a   Hovendal, Claus ^a   Mortensen, Michael Bau ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; COMPARATIVE STUDY; DENMARK; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; MORTALITY; OUTCOME ASSESSMENT; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; STOMACH TUMOR; SURVIVAL RATE;

DENMARK; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PANCREATIC NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 58149231427     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Engeland A, Haldorsen T, Dickman PW et al. Relative survival of cancer patients - a comparison between Denmark and the other Nordic countries. Acta Oncol 1998;37:49-59.
2. Jensen LS, Parvaiz I, Utzon J et al. Esophagusresektioner i Danmark 1997-2000. Ugeskr Læger 2002;164:4423-7.
3. Trillingsgaard J, Moesgaarde FA, Burcharth F et al. Pancreatikoduodenektomi i Danmark 1996-2001. Ugeskr Læger 2004;166:3595-7.
4. Lauritsen M, Bendixen A, Jensen LS et al. Ventrikelresektion for cancer i Danmark 1999-2004. Ugeskr Læger 2005;167:3048-51.
5. Jensen LS, Bendixen A, Kehlet H. Organisation and early outcomes of major upper gastrointestinal cancer surgery in Denmark 1996-2004. Scand J Surg 2007;96:41-5.
6. McCulloch P, Ward J, Tekkis PP. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 2003;327:1192-7.
7. Mortensen MB, Fristrup CW, Ainsworth AP et al. Combined preoperative endoscopic and laparoscopic ultrasonography for prediction of R0 resection in upper gastrointestinal tract cancer. Br J Surg 2006;93:720-5.
8. Hofstetter W, Swisher SG, Correa AM et al. Treatment outcomes of resected esophageal cancer. Ann Surg 2002;236:376-84.
9. Gebski V, Burmeister B, Smithers BM et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a metaanalysis Lancet Oncol 2007;8:226-34.
10. Winter JM, Cameron JL, Campbell KA et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 2006;10:1199-210.
11. Siriwardana HP, Siriwardena AK. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 2006;93:662-73.
12. Wagner M, Redaelli C, Lietz M et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 2004;91:586-94.
13. Kiil J, Henneberg EW. Større kirurgiske indgreb i øvre abdomen ved et mellemstort sygehus - Går det an? Ugeskr Læger 2006;168:1529-33.
14. Stocken DD, Buchler MW, Dervenis C et al. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 2005;92:1372-81.
15. Jensen LS, Pilegaard HK, Puho E et al. Outcome after transthoracic resection of carcinoma of the oesophagus and oesophago-gastric junction. Scand J Surg 2005;94:191-6.
16. Stilidi I, Davydov M, Bokhyan V et al. Subtotal esophagectomy with extended 2-field lymph node dissection for thoracic esophageal cancer. Eur J Cardiothorac Surg 2003;23:415-20.
17. Cuschieri A, Weeden S, Fielding J et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999;79:1522-30.
18. Hillingso JG, Hviid K, Mynster T et al. Kirurgisk behandling af cancer ventriculi på et universitetshospital. Ugeskr Læger 2001;163:1260-4.
19. Martin RC, Jaques DP, Brennan MF et al. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity. Ann Surg 2002;236:159-65.
20. Kuhlmann KF, de Castro SM, Wesseling JG et al. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer 2004;40:549-58.